NGM Biopharmaceuticals (NGM) Earnings Date, Estimates & Call Transcripts → Biden replacement revealed? (From Paradigm Press) (Ad) Free NGM Stock Alerts $1.54 -0.02 (-1.28%) (As of 04/4/2024) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateMar. 11EstimatedActual EPS (Mar. 11) -$0.33 Beat By $0.04 Consensus EPS (Mar. 11) -$0.37 Get NGM Biopharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for NGM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNGM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NGM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now NGM Biopharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.46)($0.46)($0.46)Q2 20241($0.49)($0.49)($0.49)Q3 20241($0.50)($0.50)($0.50)NGM Earnings Date and InformationNGM Biopharmaceuticals last posted its earnings data on March 11th, 2024. The reported ($0.33) earnings per share for the quarter, topping analysts' consensus estimates of ($0.37) by $0.04. The company had revenue of $0.17 million for the quarter, compared to analyst estimates of $2 million. NGM Biopharmaceuticals has generated ($1.72) earnings per share over the last year (($1.72) diluted earnings per share). Earnings for NGM Biopharmaceuticals are expected to grow in the coming year, from ($0.93) to ($0.78) per share. Read More NGM Biopharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/11/2024Q4 2023($0.37)($0.33)+$0.04($0.33)$2.00 million$0.17 million11/2/2023Q3 2023($0.40)($0.35)+$0.05($0.35)$1.10 million$0.58 million8/3/2023Q2 2023($0.46)($0.46)-($0.46)$2.47 million$1.42 million5/4/2023Q1 2023($0.52)($0.58)($0.06)($0.58)$6.93 million$2.25 million2/28/2023Q4 2022($0.52)($0.45)+$0.07($0.45)$6.83 million$18.18 million11/3/2022Q3 2022($0.61)($0.59)+$0.02($0.59)$7.02 million$7.91 million Get the Latest News and Ratings for NGM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NGM Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.55)($0.59)($0.04)($0.59)$13.36 million$8.29 million5/5/2022Q1 2022($0.42)($0.42)-($0.42)$22.35 million$20.95 million3/1/2022Q4 2021($0.37)($0.35)+$0.02($0.35)$20.13 million$20.96 million11/4/2021Q3 2021($0.34)($0.37)($0.03)($0.37)$18.90 million$18.58 million8/5/2021Q2 2021($0.35)($0.48)($0.13)($0.48)$22.08 million$16.77 million5/6/2021Q1 2021($0.41)($0.36)+$0.05($0.36)$21.33 million$21.58 million NGM Biopharmaceuticals Earnings - Frequently Asked Questions When did NGM Biopharmaceuticals announce their last quarterly earnings? NGM Biopharmaceuticals (NASDAQ:NGM) last announced its quarterly earning data on Monday, March 11, 2024. Learn more on NGM's earnings history. Did NGM Biopharmaceuticals beat their earnings estimates last quarter? In the previous quarter, NGM Biopharmaceuticals (NASDAQ:NGM) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.04. Learn more on analysts' earnings estimate vs. NGM's actual earnings. How much revenue does NGM Biopharmaceuticals generate each year? NGM Biopharmaceuticals (NASDAQ:NGM) has a recorded annual revenue of $4.42 million. How much profit does NGM Biopharmaceuticals generate each year? NGM Biopharmaceuticals (NASDAQ:NGM) has a recorded net income of -$142.38 million. NGM has generated -$1.72 earnings per share over the last four quarters. What is NGM Biopharmaceuticals's EPS forecast for next year? NGM Biopharmaceuticals's earnings are expected to grow from ($0.93) per share to ($0.78) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Kinnate Biopharma Earnings Results FibroGen Earnings Results LianBio Earnings Results Inovio Pharmaceuticals Earnings Results Enanta Pharmaceuticals Earnings Results Avid Bioservices Earnings Results So-Young International Earnings Results FitLife Brands Earnings Results DBV Technologies Earnings Results Vistagen Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:NGM) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NGM Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
